7SureshE.Diagnosisand management of gout:arationalaPProaeh[J].Postgrad Med,2005,81:572-579.
8Harris MD.Siegel LB.Alloway JA.Gout and hyperuricemia[J].Am Fam Physician,1999,59(4):925-34.
9Perez-Ruiz F,Calabozo M,Herrero-Beites AM,et at Improvementof renal function in patients withchronic gout after,proper control of hyperuricemia and gouty bouts[J].Postgrad Med,2000,86(3):287-91.
10Pouliot M,James MJ,McColl SR et al.Monosodium urate microcrystals induce cyclooxygenasez inhuman monocytes[J].Blood,1998,91(5):1769-76.
6Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum, 1977, 20: 895-900.
7Darmawan J, Valkenburg HA, Muirden KD, et al. The epidemiology of gout and hyperuricemia in a rural population of Java, J Rheumatol, 1992, 19: 1595-1599.
9Iwatani M, Waaada T, lwamoto Y, et al. Insulin sensitizer and urate metabolism. Nippon Rinsho, 2000, 58: 430-434.
10Yanmaanaka H, Kamatani N, Hakoda M, et al. Analysis of the genotypes for aldehyde dehydrogenase in Japanese patients with primary gout. Adv Exp Med Biol, 1994, 370: 53-56.
8Wise CM, Agudelo CA. Diagnosis and management of complicat- ed gout. Bull Rheum Dis, 1998, 47: 2-5.
9Perez-Ruiz F, Calabozo M, Herrero-Beites AM, et al. Improve- ment of renal function in patients with chronic gout after, proper control of hyperuricemia and gouty bouts. Postgrad Med, 2000, 86: 287-291.
10Terkeltaub R, Sundy JS, Schurnacher HR, et al. The inter- leukin 1 inhibitor rilonacept in treatment of chronic gouty arthri- tis: results of a placebo controlled monosequence crossover, non- randomized single-blind pilot study. Ann Rheum Dis, 2009, 68: 1613-1617.
